Wednesday, April 16, 2025 6:39:23 AM
He has the most to gain with ELTP's success as the largest shareholder.
Yes, and he also is the only one to gain with Mikah's success. He has repeatedly used Mikah to drain wealth from Elite shareholders, and now he is set up to make himself a Big Beautiful Deal for Mikah that leaves Elite shareholders out in the cold. Mikah has never been anything other than a parasite that sucks wealth from Elite, and it will continue to do so until we make it stop. Our biggest Mikah expense ever will be at the time of buyout. Hakim will make a secret side deal for Mikah that will have a detrimental impact on the buyout price for Elite, and we will never know how badly we were screwed or how massively Mikah wins again.
Ask yourself: as the largest shareholder in Elite, wouldn't it be to Hakim's benefit to clear the 79 million warrants that drag down our net income every time the share price goes up? Why wouldn't he execute these cashless warrants now so they stop being a liability for the rest of us? How did awarding himself 79 million warrants benefit the rest of Elite shareholders? How does their continued existence help anyone but Hakim?
No other CEO in America acts like this. His self-serving behavior is foreign. Hakim's repeated failures at fulfilling his fiduciary duty has been a disaster for Elite shareholders and will become a catastrophe at buyout. Just because he is the largest shareholder in Elite doesn't mean that his interests are aligned with the rest of Elite shareholders. The parasite Mikah is getting fatter by the minute and will be fully engorged after the buyout. Flick the tick. Tell Hakim if he is serious about pursuing a buyout now then it is time to get rid of Mikah forever and get rid of his warrants, too. Repeal the Mikah Tax.
.
Repeal the Mikah Tax -- To be paid by all shareholders at buyout
1. Cost of Second Tier Suitors
2. Cost of Secret Side Deal with Hakim
3. Cost of Mikah litigation
4. Cost of remaining OTC
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
